| Titolo |
Pubblicato in |
Anno |
| Precision medicine: Beyond AI |
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE UPDATE |
2024 |
| Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature |
CANCERS |
2024 |
| MIRROR: miRNA regulation-level differential network to study sex and ethnic disparities in cancer |
Proceedings of the 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) |
2024 |
| Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer |
JOURNAL OF CLINICAL ONCOLOGY |
2023 |
| Efficacy and safety of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis |
CANCER TREATMENT REVIEWS |
2023 |
| Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients |
CURRENT ONCOLOGY |
2023 |
| Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings |
CANCERS |
2023 |
| Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer |
CLINICAL CANCER RESEARCH |
2023 |
| Palliative sedation and time to death in home palliative care: retrospective analysis |
BMJ SUPPORTIVE & PALLIATIVE CARE |
2023 |
| La medicina di precisione come opera d’arte collettiva |
RECENTI PROGRESSI IN MEDICINA |
2023 |
| Safety of extended interval dosing immune checkpoint inhibitors. A multicenter cohort study |
JOURNAL OF THE NATIONAL CANCER INSTITUTE |
2023 |
| High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status |
JOURNAL OF HEMATOLOGY & ONCOLOGY |
2022 |
| Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years |
CANCERS |
2022 |
| Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario |
ESMO OPEN |
2022 |
| EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature |
TRANSLATIONAL LUNG CANCER RESEARCH |
2022 |
| New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis |
CANCER TREATMENT REVIEWS |
2022 |
| Patients' Satisfaction with Breakthrough Cancer Pain Therapy. A Secondary Analysis of IOPS-MS Study |
CANCER MANAGEMENT AND RESEARCH |
2022 |
| [Medical cannabis. Facilitate the proposal and sustainability for the training of healthcare personnel and the conduct of clinical trials in the cancer population.] |
RECENTI PROGRESSI IN MEDICINA |
2022 |
| Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer |
EUROPEAN JOURNAL OF CANCER |
2022 |
| DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients |
ANNALS OF ONCOLOGY |
2022 |
